Hepatic progenitor cells from adult human livers for cell transplantation

Weiss, T. S.; Lichtenauer, M.; Kirchner, S.; Stock, P.; Aurich, H.; Christ, B.; Brockhoff, G.; Kunz-Schughart, L .A.; Jauch, K.-W.; Schlitt, H.-J.; Thasler, W. E.
August 2008
Gut;Aug2008, Vol. 57 Issue 8, p1129
Academic Journal
Objective: Liver regeneration is mainly based on cellular self-renewal including progenitor cells. Efforts have been made to harness this potential for cell transplantation, but shortage of hepatocytes and premature differentiated progenitor cells from extra-hepatic organs are limiting factors. Histological studies implied that resident cells in adult liver can proliferate, have bipotential character and may be a suitable source for cell transplantation. Methods: Particular cell populations were isolated after adequate tissue dissociation. Single cell suspensions were purified by Thy-1 positivity selection, characterised in vitro and transplanted in immunodeficient Pfp/Rag2 mice. Results: Thy-1+ cells that are mainly found in the portal tract and the surrounding parenchyma, were isolated from surgical liver tissue with high yields from specimens with histological signs of regeneration. Thy-1+ cell populations were positive for progenitor (CD34, c-kit, CK14, M2PK, OV6), biliary (CK19) and hepatic (HepPar1) markers revealing their progenitor as well as hepatic and biliary nature. The potential of Thy-1+ cells for differentiation in vitro was demonstrated by increased mRNA and protein expression for hepatic (CK18, HepPar1) and biliary (CK7) markers during culture while progenitor markers CK14, chromogranin A and nestin were reduced. After transplantation of Thy-1+ cells into livers of immunodeficient mice, engraftment was predominantly seen in the periportal portion of the liver lobule. Analysis of in situ material revealed that transplanted cells express human hepatic markers HepPar1 and albumin, indicating functional engraftment. Conclusion: Bipotential progenitor cells from human adult livers can be isolated using Thy-1 and might be a potential candidate for cell treatment in liver diseases.


Related Articles

  • Renal transplantation in a 14-year-old girl with vitamin B12-responsive cblA-type methylmalonic acidaemia. Coman, D.; Huang, J.; McTaggart, S.; Sakamoto, O.; Ohura, T.; McGill, J.; Burke, J. // Pediatric Nephrology;Feb2006, Vol. 21 Issue 2, p270 

    Renal tubular dysfunction and chronic renal failure are well recognised complications of methylmalonic acidaemia (MMA) and can occur even in the context of optimal medical metabolic management. Organ transplantation, such as renal and combined liver and renal transplants, have been utilised in...

  • Reducing shortages.  // Mayo Clinic Health Letter;Oct2004 Supplement, Vol. 22, p6 

    Focuses on the new ways to address organ shortages. Transplantation of cells into a diseased organ; Use of drugs to induce healthy cells of a diseased organ; Collection of organs from genetically modified pigs.

  • New Technologies for Organ Replacement and Augmentation. Cascalho, Marilia; Platt, Jeffrey L. // Mayo Clinic Proceedings;Mar2005, Vol. 80 Issue 3, p370 

    The most common causes of disability and death are diseases of the heart, lungs, liver, kidneys, and pancreas, many of which are potentially treated by organ transplantation. The effect of organ dysfunction and failure will likely grow over time, and patients will Increasingly expect...

  • Stem Cells and Liver Disease. Akhter, Javed; Ali Aziz, Ashraf; Al Ajlan, Abdulaziz // Internet Journal of Medical Update;Jul2011, Vol. 6 Issue 2, p69 

    Liver transplantation is the primary treatment for various end-stage hepatic diseases but is hindered by the lack of donor organs, complications associated with rejection and immunosuppression. An increasingly unbridgeable gap exists between the supply and demand of transplantable organs. Hence...

  • Turkish Transplant Registry: a comparative analysis of national activity with the EBMT European Activity Survey. Arat, M.; Arpact, F.; Erten, M.; Gürman, G. // Bone Marrow Transplantation;Aug2008 Supplement, Vol. 42, pS142 

    SCT is a curative approach using chemo-, radio- and immunotherapy for malignant and non-malignant hematological disorders. The European Group for Blood and Marrow Transplantation (EBMT) has been collecting yearly data on a survey basis since 1990. The variables within the survey are limited to...

  • Transmission of Integrated Human Herpesvirus 6 through Stem Cell Transplantation: Implications for Laboratory Diagnosis. Clark, Duncan A.; Nacheva, Elisabeth P.; Hoe Nam Leong; Brazma, Diana; Ying Ting Li; Tsao, Edward H. F.; Buyck, Hubertus C. E.; Atkinson, Claire E.; Lawson, Heather M.; Potter, Michael N.; Griffiths, Paul D. // Journal of Infectious Diseases;4/1/2006, Vol. 193 Issue 7, p912 

    We identified a stem cell donor with chromosomally integrated human herpesvirus (HHV)-6 and monitored the recipient for HHV-6 after transplantation. The appearance and subsequent increase in HHV-6 load paralleled engraftment and an increase in white blood cell count. Fluorescent in situ...

  • Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors. Kröger, Nicolaus; Zabelina, Tatjana; Krüger, William; Renges, Helmut; Stute, Norbert; Dürken, Matthias; Graf von Finkenstein, Friedrich; Erttmann, Rolf; Kabisch, Hartmut; Schafhausen, Philipe; Jaburg, Nicole; Löliger, Cornelius; Zander, Axel R // Annals of Hematology;Apr2001, Vol. 80 Issue 4, p209 

    To reduce the incidence of GvHD and the rate of graft failure in unrelated stem cell transplantation, we incorporate anti-thymocyte globulin in the preparative regimen in 98 patients with hematological or inherited storage disease. The median age was 32 years (range: 1–56) and 84 patients...

  • CMV infections after hematopoietic stem cell transplantation. Ljungman, P. // Bone Marrow Transplantation;Aug2008 Supplement, Vol. 42, pS70 

    CMV can cause disease in several different organs after SCT. Seropositivity remains a major risk factor for TRM in unrelated SCT patients. In a study using the EBMT registry, CMV-seropositive patients receiving seropositive unrelated donor grafts had improved survival and reduced TRM compared...

  • Transplant News.  // Transplant News;Oct2012, Vol. 22 Issue 10, p8 

    The article offers news briefs as of October 2012 on organ transplant. A new study has revealed that offering tax incentives to organ donors is unable to increase the US donor supply. A University of Maryland study has suggested that neonatal cardiac stem cells may aid in restoring heart...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics